Predictive value of serum globulin levels for the extent of hepatic fibrosis in patients with chronic hepatitis B infection

Journal of Viral Hepatitis

Volumn 13, Issue 10, 2006, Pages 671-677

  Schmilovitz Weiss, H ^a   Tovar, A ^b   Halpern, M ^b   Sulkes, J ^c   Braun, M ^d,e   Rotman, Y ^d,e   Tur Kaspa, R ^d,e   Ben Ari, Z ^d,e,f  

^a Gastroenterology Unit   (Italy)

^b Department of Pathology ^*

^c Epidemiology Unit

^d Liver Institute   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

^f RABIN MEDICAL CENTER   (Israel)

Author keywords

Globulins; HBV infection; Hepatic fibrosis; Immunoglobulins

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; GLOBULIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; ARTICLE; BIOCHEMISTRY; CHRONIC HEPATITIS; CONFIDENCE INTERVAL; FEMALE; HEPATITIS B; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; SEROLOGY; THROMBOCYTE COUNT; UNIVARIATE ANALYSIS; VIROLOGY;

ADULT; BIOLOGICAL MARKERS; CHRONIC DISEASE; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOGLOBULINS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SERUM GLOBULINS; SEVERITY OF ILLNESS INDEX;

EID: 33748754092     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2006.00744.x     Document Type: Article

References (35)

1. Fattovich G, Brollo L, Giustina G et al. Natural history and prognostic factors for chronic hepatitis type B. Gut 1991; 32: 294-298.
2. Ikeda K, Saitoh S, Suzuki Y et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2,215 patients. J Hepatol 1998; 28: 930-938.
3. Befeler A, DiBisceglie A. Hepatitis B. Dis Clin North Am 2000; 14: 617-632.
4. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2001; 34: 1225-1241.
5. Liaw YF, Tai DL, Chu CM, Chen TJ. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 1988; 8: 493-496.
6. Yu MW, Hsu FC, Sheen IS et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 1997; 145: 1039-1047.
7. Weissberg JI, Andres LL, Smith CI et al. Survival in chronic hepatitis B. An analysis of 379 patients. Ann Intern Med 1984; 101: 613-616.
8. Chien RN, Liaw YF, Atkins M. Pretherapy alanine transaminase level as a determinant for hepatitis Be antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group. Hepatology 1999; 30: 770-774.
9. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000; 32: 477-481.
10. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-1457.
11. Regev A, Berho M, Jeffers LJ et al. Sampling error and intraobserver variations in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 98: 2614-2618.
12. Pasha T, Gabriel S, Therneau T et al. Cost-effectiveness of ultrasound-guided liver biopsy. Hepatology 1998; 27: 1220-1226.
13. Giustina G, Fattovitch G, De Paoli M et al. Serum procollagen type III peptide in chronic hepatitis B. Relationship to disease activity and response to interferon-alpha therapy. Int J Clin Lab Res 1996; 26: 33-36.
14. Pontinha N, Pessegueiro H, Barros H. Serum hyaluronan as a marker of liver fibrosis in asymptomatic chronic viral hepatitis B. Scand J Clin Lab Invest 1999; 59: 345-347.
15. Murawaki Y, Ikuta Y, Idobe Y, Kawasaki H. Serum metalloproteinase-1 in patients with chronic viral hepatitis. J Gastroenterol Hepatol 1999; 14: 138-145.
16. Murawaki Y, Nishimura Y, Ikuta Y, Idobe Y, Kitamura Y, Kawasaki H. Plasma transforming growth factor-beta 1 concentrations in patients with chronic viral hepatitis. J Gastroenterol 1998; 13: 680-684.
17. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069-1075.
18. Myers RP, Tainturier MH, Ratziu V et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis. Br J Hepatol 2003; 39: 222-230.
19. Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, Contreras R. Noninvasive diagnosis of liver cirrhosis using DNA sequenced-based total serum protein glycomics. Nat Med 2004; 10: 1-6.
20. Forns X, Ampurdanes S, Llovet JM et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002; 36: 986-992.
21. Wai CT, Greenson JK, Fontana RJ et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-526.
22. Czaja AJ, Wolf AM, Baggenstoss AH. Clinical assessment of cirrhosis in severe chronic liver disease: specificity and sensitivity of physical and laboratory findings. Mayo Clin Proc 1980; 55: 360-364.
23. Husby G, Skrede S, Blomhoff JP, Jacobsen CD, Berg K, Gjone E. Serum immunoglobulins and organ-specific antibodies in diseases of the liver. Scand J Gastroenterol 1977; 12: 297-304.
24. Mutchnick MG, Lederman HM, Missirian A, Johnson AG. In vitro synthesis of IgG by peripheral blood lymphocyte in chronic liver disease. Clin Exp Immunol 1981; 43: 370-375.
25. Prytz H, Bjorneboe M, Christoffersen P, Poulsen H, Orskov F. Correlation between hepatic morphology and immunoglobulins and antibodies to Escherichia coli in cirrhosis. Gut 1977; 18: 28-32.
26. Shen H, Zhang M, Kaita K, Minuk GY, Rempel J, Gong Y. Expression of Fc fragment receptors of immunoglobulin G (Fc gammaRs) in rat hepatic stellate cells. Dig Dis Sci 2005; 50: 181-187.
27. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115: 209-218.
28. Watt K, Uhanova J, Gong Y et al. Serum immunoglobulins predict the extent of hepatic fibrosis in patients with chronic hepatitis C virus infection. J Viral Hepat 2004; 11: 251-256.
29. Desmet D, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520.
30. Friedman SL. Stellate cells: a moving target in hepatic fibrogenesis. Hepatology 2004; 40: 1041-1043.
31. Hui AY, Chan HLY, Wong VWS, Liew CT. et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol 2005; 100: 616-623.
32. Giannini E, Risso D, Botta F et al. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease activity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med 2003; 163: 218-224.
33. Aster R. Pooling of platelets in the spleen: role in the pathogenesis 'hypersplenic' thrombocytopenia. J Clin Invest 1996; 45: 645-657.
34. Kawasaki T, Takeshita A, Souda K, Kobayashi Y et al. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis. Am J Gastroenterol 1999; 94: 1918-1922.
35. Silvain C, Patry C, Launay P, Lehuen A, Monteiro RC. Altered expression of monocyte IgA Fc receptors is associated with defective endocytosis in patients with alcoholic cirrhosis. Potential role for IFN-gamma. J Immunol 1995; 155: 1606-1618.